Sasaki, Hikaru http://orcid.org/0000-0001-7380-1931
Kitamura, Yohei
Toda, Masahiro
Hirose, Yuichi
Yoshida, Kazunari
Funding for this research was provided by:
Japan Society for the Promotion of Science (15K10343, 19K09490)
Eisai (HHCS20200922004)
Article History
Received: 10 January 2024
Accepted: 25 March 2024
First Online: 2 April 2024
Declarations
:
: HS received grant for clinical trial which was not related to the contents of the present work from Ono pharmaceutical. HS received research grant from Eisai pharmaceutical in 2020 and 2021, a part of which was used for histological study. The authors declare there is no conflict of interest concerning the contents of the present work.
: Treatment with neoadjuvant strategy and histopathological investigation were performed with approval by the institutional review board (20130250, 20050002).